Company News Summary | 16 Sep 2021
Click the print icon in your browser to print this report. Currency is in AUD unless otherwise specified
Australian Pharmaceutical Industries Announces Regarding Revised Non-Binding Indicative Proposal from Wesfarmers
10:02:00 | Associate analysts
Original annuncemenet:Revised Non-Binding Indicative Proposal from Wesfarmers
Australian Pharmaceutical Industries announced that it had received a non-binding indicative proposal from Wesfarmers to acquire 100% of the shares in the Company for cash consideration of $1.38 per share. This proposal was rejected by the Company Board on 29 July 2021. The Company announces that it has received a revised non-binding indicative proposal (Revised Indicative Proposal) from Wesfarmers to acquire 100% of the shares in the Company, by way of a scheme of arrangement, for cash consideration of $1.55 per share.
|This report appeared on www.morningstar.com.au||2021 Morningstar Australasia Pty Limited|
© Copyright 2021 Morningstar Australasia Pty Ltd ABN: 95 090 665 544 ("Morningstar"), AFSL no 240892. (a subsidiary of Morningstar, Inc.). This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written content of Morningstar. Some of the material provided is published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO").